Europe Oncology Therapeutics Market Analysis

Europe Oncology Therapeutics Market Analysis

$ 3999

This report presents a strategic analysis of the Europe Oncology Therapeutics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Europe Oncology Therapeutics Market, offering unmatched value, accuracy and expert insights.

ID: IN10EUPH042 CATEGORY: Pharmaceuticals GEOGRAPHY: Europe

Buy Now

Europe Oncology Therapeutics Executive Summary

The European Union's fastest-growing economy in 2021 was Ireland, with the country's GDP growing by 13.5 percent that year. With a GDP of almost 3.3 trillion Euros, Germany is by far Europe's largest economy, followed by the United Kingdom at 2.28 trillion Euros and France at 2.27 trillion Euros.

Even though unemployment in the EU is currently low, the inflation rate hit a new high of 7.8% in March 2022. Going into 2022, Europe's growth rate is anticipated to be 2.7 percent, with Portugal having the fastest growth rate of 5.8 percent and Estonia having the slowest growth rate of one percent

The pharmaceutical industry covers all aspects of medication research, development, production, and distribution. Pharma revenues worldwide reached $1.42 trillion in 2021 due to the market's rapid growth over the previous two decades. With the introduction of new technology as well as more economical and effective manufacturing techniques, the industry has experienced a significant transition. Additionally, the market growth has been positively driven by rising investment flow in this sector.

Cancer therapy refers to the process of halting or slowing the growth of tumors that are causing cancer in the patient's body. It emphasizes the alterations that take place in cancer cells. Surgery, radiation, and chemotherapy are all progressively added. There are various cancer treatment and therapy applications, nevertheless, depending on the stage and type of the disease.

Market Size and Key Findings

The global Oncology Therapeutics market is estimated to be valued at US$ 0.286 Bn in 2021 and is expected to exhibit a CAGR of 8.2% over the forecast period (2021-2030).

Europe Oncology Therapeutics Size (In USD Bn) (2021-2030F)

Market Dynamics

Market Growth Drivers Analysis

Oncology treatment and oncology diagnostics are in high demand due to the expanding investments and innovations in the biopharmaceutical sector, which is promoting the development of a variety of novel medications and therapies. The population's increasing awareness of the availability of numerous oncology-related treatments and diagnostics is anticipated to fuel the expansion of the worldwide oncology market. The market participants are being drawn to participate in the oncology sector by its growing importance and better profit potential.

Market Restraints

Chemotherapy medications kill cancer cells, but they also harm healthy body cells. For the patients, this has a variety of negative side effects. Bone marrow suppression, gastrointestinal issues, neuropathies, hair loss, lethargy, and skin issues are among the most typical side effects. As a result, the market's expansion is being significantly impacted by these side effects of oncology medications.

Other factors that are preventing the Europe market from expanding throughout the projection period include strict government regulations, expensive medication, and patent expiration.

Competitive Landscape

Key Players

The prominent players operating in this market include AbbVie, Inc. (USA), Amgen, Inc. (USA), Astellas Pharma, Inc. (Japan), Takeda Pharmaceutical Company Limited (Japan), Celgene Corporation (USA), Eli Lilly and Company (USA), Bayer AG (Germany), GlaxoSmithKline Plc (UK), AstraZeneca Plc. (UK), Johnson & Johnson Services, Inc. (USA), Pfizer, Inc. (USA), Merck KGaA (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), and Novartis AG (Switzerland)

1. Report Description of the Europe Oncology Therapeutics
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report

2. Europe Oncology Therapeutics Executive Summary
2.1 Europe Oncology Therapeutics – Industry Snapshot & key buying criteria, 2021-2030
2.2 Market Size, Growth Prospects, and Key findings

3. Market Dynamics of Europe Oncology Therapeutics
3.1 Market Growth Drivers Analysis
3.2 Market Restrains Analysis

4. Europe Oncology Therapeutics Segmentation

4.1 By Application
4.1.1 Blood Cancer
4.1.2 Colorectal Cancer
4.1.3 Gastrointestinal Cancer
4.1.4 Gynaecologic Cancer
4.1.5 Breast Cancer
4.1.6 Lung Cancer
4.1.7 Prostate Cancer
4.1.8 Others

4.2 By Drugs
4.2.1 Revlimid
4.2.2 Avastin
4.2.3 Herceptin
4.2.4 Rituxan
4.2.5 Opdivo
4.2.6 Gleevec
4.2.7 Velcade
4.2.8 Imbruvica
4.2.9 Ibrance
4.2.10 Zytiga
4.2.11 Alimta
4.2.12 Xtandi
4.2.13 Tarceva
4.2.14 Perjeta
4.2.15 Temodar
4.2.16 Others

4.3 By Therapy
4.3.1 Chemotherapy
4.3.2 Targeted Therapy
4.3.3 Immunotherapy
4.3.4 Hormonal Therapy
4.3.5 Others

4.4 By Route of Administration
4.4.1 Oral
4.4.2 Parenteral
4.4.3 Others

4.5 By Distribution Channel
4.5.1 Hospital Pharmacies
4.5.2 Retail Pharmacies
4.5.3 Online Pharmacies
4.5.4 Others

5. Europe Oncology Therapeutics Share
5.1 Market Analysis, Insights, and Forecast – By Revenue

6. Competitive Landscape
6.1 Major Top Market Players

7. Key Company Profiles

7.1 Company 1
7.1.1 Overview
7.1.2 Financial Performance
7.1.3 Product & Services
7.1.4 Strategic initiatives

7.2 Company 2
7.2.1 Overview
7.2.2 Financial Performance
7.2.3 Product & Services
7.2.4 Strategic initiatives

7.3 Company 3
7.3.1 Overview
7.3.2 Financial Performance
7.3.3 Product & Services
7.3.4 Strategic initiatives

7.4 Company 4
7.4.1 Overview
7.4.2 Financial Performance
7.4.3 Product & Services
7.4.4 Strategic initiatives

7.5 Company 5
7.5.1 Overview
7.5.2 Financial Performance
7.5.3 Product & Services
7.5.4 Strategic initiatives

8. Healthcare Policies and Regulatory Landscape
8.1 Healthcare Policies in Europe
8.2 Regulatory Framework in Europe
8.3 Pricing & Reimbursement Scenario in Europe Oncology Therapeutic

9. Factors Driving Future Growth
9.1 New Trends and Development Europe Oncology Therapeutics
9.2 Future Opportunities

10. Strategic Recommendations

Oncology Therapeutics Segmentation

By Application (Revenue, USD Billion):

  • Blood Cancer
  • ?Colorectal Cancer
  • Gastrointestinal Cancer
  • Gynaecologic Cancer
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • ?Others

By Drugs (Revenue, USD Billion):

  • Revlimid
  • Avastin
  • Herceptin
  • Rituxan
  • Opdivo
  • Gleevec
  • Velcade
  • Imbruvica
  • Ibrance
  • Zytiga
  • Alimta
  • Xtandi
  • Tarceva
  • Perjeta
  • Temodar
  • Others

By Therapy (Revenue, USD Billion):

  • Chemotherapy
  • Targeted Therapy
  • Immunotherapy
  • Hormonal Therapy
  • Others

By Route of Administration (Revenue, USD Billion):

  • Oral
  • Parenteral
  • Others

By Distribution Channel (Revenue, USD Billion):

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • ?Others

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.


Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:



Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.



Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.

We value your inquiry and offer free customization with every report to fulfil your exact research needs.

This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 04 January 2023

Related reports (by category)

Related reports (by geography)

subscribe to our newsletter